Brief: Karyopharm Therapeutics Q3 Net Income USD -32.072 Million
Nov 05 (Reuters) - Karyopharm Therapeutics Q3 operating expenses USD 65.066 million. * Q3 operating income USD -26.283 million * Q3 product revenue USD 29.516 million * outlook FY revenue USD 145-155 million